Company: VERA
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0000950170-25-063975
Chunk: 1

Company: Vera Therapeutics, Inc.
Filing Date: 2025-05-06
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                   
         99.1      Press Release of Vera Therapeutics, Inc., dated May 6, 2025.                  
 ─────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                       Vera Therapeutics, Inc.              
  Date:      May 6, 2025      By:      /s/ Sean Grant                       
                                       Sean Grant, Chief Financial Officer